Sexual Dysfunction Clinical Trial
Official title:
Safety and Efficacy of Hybrid Fractional Laser Treatment for Symptoms of Genitourinary Syndrome of Menopause
Verified date | August 2020 |
Source | Sciton |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 nm lasers for treatment of symptoms of Genitourinary Syndrome of Menopause.
Status | Completed |
Enrollment | 60 |
Est. completion date | February 25, 2020 |
Est. primary completion date | February 25, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 40 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Healthy biological female aged between 40 to 70 years 2. Is post-menopausal with a AND b OR c 1. No menses for at least 12 months 2. Follicle-stimulating hormone (FSH) level over 40mlU/mL 3. Has had a bilateral oophorectomy at least 12 months ago with no hormone replacement 3. Is experiencing at least two self-reported symptoms of GSM, such as 1. Vaginal irritation in absence of infection 2. Chronic burning sensation 3. Chronic itching in the absence of infection 4. Recurring urinary tract infections (UTIs) 5. Vaginal dryness during sexual activity 6. Pain during sexual activity (dyspareunia) 4. Has been experiencing symptoms of GSM for greater than 3 months 5. Is unable due to medical contraindication or unwilling to receive hormone-based vaginal therapy 6. Normal and up-to-date pap smear if applicable 7. Is sexually active (i.e. intravaginal intercourse) or has the potential and desire to be sexually active if symptoms of GSM improve 8. Can read, understand and sign informed consent form Exclusion Criteria: 1. Undiagnosed abnormal genital bleeding 2. Has history of pelvic surgery or other energy-based vaginal therapy within 6 months prior to enrollment 3. Previous use of topical estrogen therapy within the last 3 months 4. Has used vaginal creams, moisturizers, lubricants or homeopathic preparations or received anticoagulants, antiplatelet, thrombolytic, vitamin E or anti-inflammatory within 2 weeks of treatment 5. History of heart failure 6. Has equal to or greater than stage III prolapse, according to pelvic organ prolapse quantification system (POP-Q) 7. Has an active sexually transmitted infection (STI) 8. Has signs or symptoms of vaginitis/vulvitis 9. Has signs or symptoms of acute urinary tract infection (UTI) 10. Has participated in any clinical trial involving an investigational drug or procedure within the past 30 days 11. The investigator feels that for any reason the subject is not eligible to participate in the study |
Country | Name | City | State |
---|---|---|---|
United States | Carolinas Healthcare System | Charlotte | North Carolina |
United States | Women's Pelvic Health Institute | Los Gatos | California |
United States | Louisiana State University | New Orleans | Louisiana |
United States | The Female Pelvic Medicine Institute of Virginia | North Chesterfield | Virginia |
United States | Coyle Institute | Pensacola | Florida |
United States | Woodlands Gynecology & Aesthetics | The Woodlands | Texas |
Lead Sponsor | Collaborator |
---|---|
Sciton |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in Vaginal Maturation Index (VMI) | An objective assessment of vaginal hormone response as well as overall hormonal environment by calculating a ratio of parabasal cells, intermediate cells, and superficial cells | 12 months | |
Secondary | Change from baseline in Histology | Change from baseline in epithelial thickness, collagen, elastin, vascularity, and fibroblast density. | 12 months | |
Secondary | Change from baseline in Vaginal Health Index Score (VHIS) | A quantitative assessment of vaginal health that evaluates vaginal elasticity, fluid volume, pH, epithelial integrity, and moisture on a scale of 1 to 5. | 12 months | |
Secondary | Change from baseline in Female Sexual Function Index (FSFI) | A multidimensional self-report instrument for assessment of female sexual function. | 12 months | |
Secondary | Change from baseline in Day-to-Day Impact of Vaginal Aging Questionnaire (DIVA) | A multidimensional self-report measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. | 12 months | |
Secondary | Change from baseline in Clinical Photography | Change from baseline in the appearance of the treatment area. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039775 -
Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation.
|
N/A | |
Recruiting |
NCT05380856 -
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
|
N/A | |
Not yet recruiting |
NCT05918770 -
Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients
|
N/A | |
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT02430987 -
Low Sexual Desire and Metabolic Syndrome
|
N/A | |
Completed |
NCT02837796 -
Effects of Trans-Obturator Tape outside-in Versus Inside-out Procedure for Stres Urinary Incontinence
|
N/A | |
Completed |
NCT01434290 -
Radiation Therapy in Treating Patients With Prostate Cancer
|
Phase 2 | |
Completed |
NCT01660152 -
Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery
|
N/A | |
Active, not recruiting |
NCT00981305 -
Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors
|
Phase 3 | |
Completed |
NCT04964895 -
Sexual Quality of Patients After Bladder Cancer Cystectomy
|
N/A | |
Enrolling by invitation |
NCT05832268 -
Pelvic Floor Function After Obstetric Injury to the Anal Sphincter
|
||
Completed |
NCT04066218 -
Sexual Function Screening in Childhood Cancer Survivors
|
||
Not yet recruiting |
NCT05530681 -
Correlation Pelvic Floor Function and Ultrasound Findings One Year After Childbirth
|
N/A | |
Recruiting |
NCT05826691 -
Benign Prostate Surgery and QOL and Sexual Function
|
||
Completed |
NCT04560283 -
HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period
|
Phase 4 | |
Completed |
NCT03232801 -
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
|
N/A | |
Suspended |
NCT04544735 -
Improving Women's Function After Pelvic Radiation
|
N/A | |
Completed |
NCT05732844 -
Efficacy of the Use of Vaginal Balls for the Improvement of Urinary Incontinence and Sexual Function in Women.
|
N/A | |
Recruiting |
NCT05097469 -
Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Sexual Dysfunction.
|
N/A | |
Withdrawn |
NCT01635543 -
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
|
N/A |